Health Delivery

English

Getting it right for kids with diabetes – everywhere

Type 1 diabetes is one of the most common chronic diseases in childhood, and the number of children developing type 1 diabetes is growing rapidly. Overall, type 1 diabetes in children worldwide is increasing 3% annually (79,100), with the greatest incidence documented in Europe and the North America and Caribbean Region.

Assurer une prise en charge efficace des personnes atteintes de diabète LADA

Le diabète sous toutes ses formes est l'une des maladies non transmissibles les plus prévalentes, avec des millions de personnes affectées à travers le monde. Pour 2013, la Fédération Internationale du Diabète estime à 8,3 % le nombre d'adultes ou à 382 millions le nombre de personnes actuellement atteintes d'une forme ou l'autre de diabète. Ce nombre devrait dépasser les 592 millions d'ici 2025.

Getting it right for people with LADA

In all its forms, diabetes is one of the most prevalent non-communicable diseases affecting millions of people around the world. For 2013, the International Diabetes Federation estimates that 8.3 percent of adults or 382 million people are currently living with one form of diabetes or another. This number is projected to rise beyond 592 million by 2025. At the present time, the burden of diabetes is severe causing a range of preventable complications and resulting in more than five million deaths each year.1


Getting it right for people with MODY

The overwhelming majority of the estimated 382 million people currently living with diabetes worldwide1 are among that number as a result of complex interactions between their genes and their environments. Certainly for the majority of those with type 2 diabetes and probably also for those with type 1 diabetes, genetic predisposition is the result of many genes.  It is polygenic. For a minority of the 382 million, however, diabetes is the result of a single gene.

Es el momento de hacer más por la diabetes: la inercia clínica y como combatirla

En el estudio de la física, el término "inercia" describe la resistencia al movimiento. Cuando se aplica a la medicina, la palabra inercia describe, de modo similar, la resistencia al cambio. Más concretamente, es la diferencia entre la atención médica a la que se debería aspirar y la que se logra en realidad. Los estudios han demostrado que la inercia clínica es un problema frecuente en el tratamiento de la diabetes tipo 21 (Cuadro 1).

L'heure est venue de faire plus pour le diabète en luttant contre l'inertie clinique

En physique, l'inertie décrit la résistance au mouvement. Appliqué à la médecine, ce terme décrit, de façon similaire, la résistance au changement. De manière plus spécifique, l'inertie est la différence entre les soins médicaux qui devraient être visés et ceux réellement prodigués. Des études ont montré que l'inertie clinique est un problème fréquent dans le cadre du traitement du diabète de type 21 (encadré 1). Malgré la disponibilité d'un nombre sans précédent de traitements, près de la moitié des patients continuent d'éprouver des difficultés à contrôler leur glycémie.

Time to do more for diabetes: clinical inertia and how to beat it

In the study of physics, inertia describes resistance to movement. When applied to medicine, the word inertia similarly describes resistance to change. More specifically, it is the difference between the medical care that should be aspired to and what is actually achieved. Studies have shown that clinical inertia is a common problem in the treatment of type 2 diabetes1 (Box 1). Despite the availability of more diabetes therapies than ever before, almost half of those treated still have difficulty controlling their blood glucose.

 


Creating networks for enhanced diabetes care in Kuwait and Scotland

The Kuwait-Scotland eHealth Innovation Network (KSeHIN) was established in October 2010 following the signing of a Memorandum of Understanding between the five partners: Dasman Diabetes Institute, Ministry of Heath, Kuwait, the University of Dundee, NHS Tayside, Scotland, UK and Aridhia Informatics Ltd.

 


Hype or hope for diabetes mobile health applications?

Mobile health applications (apps) created to help improve type 1 diabetes or type 2 diabetes care are perceived by their visionaries and programmers as game-changing tools which assist in the rigorous demands of diabetes self-management. People living with diabetes who have access to mobile technology are learning how to utilise technology for better blood glucose control and support, often in conjunction with their healthcare teams.

 


Schools open doors to lifestyle lessons in Tunisia


An epidemiological transition is occurring in Tunisia. Prevalence of diabetes has increased from 2.3% in 1977 to 6.4% in 1990 and reached 10 to 15% in 2000. Increased diabetes prevalence is rising hand-in-hand with obesity, which represents an important risk factor of type 2 diabetes.

Pages